Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05744414 · ClinicalTrials.gov registry record
Histological Analysis of AlloMend® Acellular Dermal Matrix Used in Breast Implant Surgeries
A clinical trial of Breast Implant; Complications, Infection or Inflammation, sponsored by AlloSource.
- Active
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT05744414 is a study of Breast Implant; Complications, Infection or Inflammation that is active but no longer recruiting, run by AlloSource. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05744414, a study of Breast Implant; Complications, Infection or Inflammation, is active but no longer recruiting, sponsored by AlloSource.
- ACTIVE NOT RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, histologic analysis of biopsied tissue obtained from participants who have undergone a pre-pectoral breast reconstruction or augmentation surgery with expander placement and AlloMend® Acellular Dermal Matrix. AlloMend® Acellular Dermal Matrix graft incorporation with surrounding native soft tissue using histological assays characterizing host cell infiltration, neovascularization, inflammation, and host replacement of ADM collagen will be studied.
Conditions Studied
Study Locations (1)
Nevada
- Janiga MDs Plastic Surgery and Cosmetic Center - Reno
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-05-17 |
| Est. Completion | 2026-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05744414
The ClinicalTrials.gov registry entry for NCT05744414 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AlloSource, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Implant; Complications, Infection or Inflammation appearing as the primary indexed condition, and to 0 interventions.
NCT05744414 reports 1 study location spanning 1 distinct geographic area - top geographies include Nevada.
Frequently Asked Questions
What is clinical trial NCT05744414 about?
NCT05744414 is a clinical study titled "Histological Analysis of AlloMend® Acellular Dermal Matrix Used in Breast Implant Surgeries". This is a prospective, histologic analysis of biopsied tissue obtained from participants who have undergone a pre-pectoral breast reconstruction or augmentation surgery with expander placement and AlloMend® Acellular Dermal Matrix. AlloMend® Acellular Dermal Matrix graft incorporation with surround...
What is the current status of trial NCT05744414?
This trial is currently active not recruiting. The enrollment target is 30 participants. The study started on 2023-05-17. Estimated completion is 2026-05.
What conditions does trial NCT05744414 study?
This clinical trial studies the following conditions: Breast Implant; Complications, Infection or Inflammation.
Who is sponsoring clinical trial NCT05744414?
This trial is sponsored by AlloSource, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05744414 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Implant; Complications, Infection or Inflammation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.